BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare ...

BURLINGTON, N.C., and EGG HARBOR TOWNSHIP, N.J.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New ...

North Carolina-based LabCorp Diagnostics, one of the largest clinical laboratories in the U.S., was forced to shut down its network on Sunday after officials detected suspicious activity, according to ...

The biomarker test measures NfL levels through standard blood collection. Labcorp has launched the Neurofilament Light Chain (NfL) blood test to identify and verify signs of neuronal damage related to ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2025 results on Oct. 28, before the market opens. The renowned laboratory service provider reported adjusted earnings of ...

Strategic Collaboration Expands Patient Access to Labcorp’s Services, Drives Efficiencies and Advances Clinical Innovation The transactions build on Labcorp’s strong track record of establishing ...

BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team ...

With a global footprint, Labcorp recently expanded its presence in New Jersey by adding 110,000 square feet at its regional facility in Somerset County. Beyond advanced laboratory space, the ...

BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood ...

Labcorp Holdings Inc. (NYSE:LH), a prominent $20.8 billion healthcare diagnostics company, announced today an expansion of its credit facilities, underscoring the company's ongoing financial strategy.